Literature DB >> 17499885

Cytotoxic 3,5-bis(benzylidene)piperidin-4-ones and N-acyl analogs displaying selective toxicity for malignant cells.

Hari N Pati1, Umashankar Das, J Wilson Quail, Masami Kawase, Hiroshi Sakagami, Jonathan R Dimmock.   

Abstract

A series of 3,5-bis(benzylidene)piperidin-4-ones 1, 1-acryloyl-3,5-bis(benzylidene)piperidin-4-ones 2 and adducts of 2 with sodium 2-mercaptoethanesulfonate (mesna), namely series 3, were prepared as candidate cytotoxic agents. These compounds were examined against neoplastic HSC-2, HSC-4 and HL-60 cells as well as HGF, HPC and HPLF normal cell lines and many of the compounds displayed selective toxicity for malignant cells. The CC50 values of the analogs in series 2 towards the cancer cell lines were mainly submicromolar. The relative potencies, selectivity and logP values were in the order of 2>1>3. The sulfonic acid group of a representative compound in series 3 was replaced by a thiol function to produce 4 leading to substantial increases in cytotoxic potencies and hydrophobicity indicating that the presence of a hydrophilic sulfonic acid group was disadvantageous in terms of potency. Molecular modeling suggested that the superior cytotoxicity of various members of series 1-3 over an acyclic analog 5 may have been due to the greater torsion angles theta1 and theta2 created between the arylidene aryl rings and the adjacent olefinic groups in series 1-3.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499885      PMCID: PMC3276587          DOI: 10.1016/j.ejmech.2007.03.010

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  15 in total

1.  Cytotoxic analogues of 2,6-bis(arylidene)cyclohexanones.

Authors:  Jonathan R Dimmock; Maniyan P Padmanilayam; Gordon A Zello; Kurt H Nienaber; Theresa M Allen; Cheryl L Santos; Erik De Clercq; Jan Balzarini; Elias K Manavathu; James P Stables
Journal:  Eur J Med Chem       Date:  2003-02       Impact factor: 6.514

Review 2.  Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy.

Authors:  M B Haselberger; T L Schwinghammer
Journal:  Ann Pharmacother       Date:  1995-09       Impact factor: 3.154

3.  Mechanism of the antigen formation of carvone and related alpha, beta-unsaturated ketones.

Authors:  A M Nilsson; E Gäfvert; L Salvador; K Luthman; M Bruze; B Gruvberger; J L Nilsson; A T Karlberg
Journal:  Contact Dermatitis       Date:  2001-06       Impact factor: 6.600

4.  Human placenta sphingomyelinase, an exogenous acidic pH-optimum sphingomyelinase, induces oxidative stress, glutathione depletion, and apoptosis in rat hepatocytes.

Authors:  C García-Ruiz; M Marí; A Morales; A Colell; E Ardite; J C Fernández-Checa
Journal:  Hepatology       Date:  2000-07       Impact factor: 17.425

5.  A conformational and structure-activity relationship study of cytotoxic 3,5-bis(arylidene)-4-piperidones and related N-acryloyl analogues.

Authors:  J R Dimmock; M P Padmanilayam; R N Puthucode; A J Nazarali; N L Motaganahalli; G A Zello; J W Quail; E O Oloo; H B Kraatz; J S Prisciak; T M Allen; C L Santos; J Balzarini; E De Clercq; E K Manavathu
Journal:  J Med Chem       Date:  2001-02-15       Impact factor: 7.446

6.  Inhibition of glutathione S-transferase activity in human melanoma cells by alpha,beta-unsaturated carbonyl derivatives. Effects of acrolein, cinnamaldehyde, citral, crotonaldehyde, curcumin, ethacrynic acid, and trans-2-hexenal.

Authors:  M L Iersel; J P Ploemen; I Struik; C van Amersfoort; A E Keyzer; J G Schefferlie; P J van Bladeren
Journal:  Chem Biol Interact       Date:  1996-10-21       Impact factor: 5.192

7.  3-Arylidene-1-(4-nitrophenylmethylene)-3,4-dihydro-1H-naphthalen-2-ones and related compounds displaying selective toxicity and reversal of multidrug resistance in neoplastic cells.

Authors:  Jonathan R Dimmock; Umashankar Das; H Inci Gul; Masami Kawase; Hiroshi Sakagami; Zoltán Baráth; Imre Ocsovsky; Joseph Molnár
Journal:  Bioorg Med Chem Lett       Date:  2005-03-15       Impact factor: 2.823

Review 8.  The role of glutathione in cancer.

Authors:  Ganesaratnam K Balendiran; Rajesh Dabur; Deborah Fraser
Journal:  Cell Biochem Funct       Date:  2004 Nov-Dec       Impact factor: 3.685

9.  Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid.

Authors:  P J O'Dwyer; F LaCreta; S Nash; P W Tinsley; R Schilder; M L Clapper; K D Tew; L Panting; S Litwin; R L Comis
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

10.  Cytotoxic 1,3-diarylidene-2-tetralones and related compounds.

Authors:  Jonathan R Dimmock; Maniyan P Padmanilyam; Gordon A Zello; J Wilson Quail; Eliud O Oloo; Jared S Prisciak; Heinz Bernhard Kraatz; Arten Cherkasov; Jeremy S Lee; Theresa M Allen; Cheryl L Santos; Elias K Manavathu; Erik De Clercq; Jan Balzarini; James P Stables
Journal:  Eur J Med Chem       Date:  2002-10       Impact factor: 6.514

View more
  20 in total

1.  3,5-Bis(benzylidene)-1-[3-(2-hydroxyethylthio)propanoyl]piperidin-4-ones: a novel cluster of potent tumor-selective cytotoxins.

Authors:  Umashankar Das; Hari N Pati; Hiroshi Sakagami; Ken Hashimoto; Masami Kawase; Jan Balzarini; Erik De Clercq; Jonathan R Dimmock
Journal:  J Med Chem       Date:  2011-04-20       Impact factor: 7.446

2.  Anticancer activity of an imageable curcuminoid 1-[2-aminoethyl-(6-hydrazinopyridine-3-carbamidyl)-3,5-bis-(2-fluorobenzylidene)-4-piperidone (EFAH).

Authors:  Pallavi Lagisetty; Dharmalingam Subramaniam; Kaustuv Sahoo; Shrikant Anant; Vibhudutta Awasthi
Journal:  Chem Biol Drug Des       Date:  2011-12-22       Impact factor: 2.817

3.  Cytotoxic 2-benzylidene-6-(nitrobenzylidene)cyclohexanones which display substantially greater toxicity for neoplasms than non-malignant cells.

Authors:  Umashankar Das; Alireza Doroudi; H Inci Gul; Hari N Pati; Masami Kawase; Hiroshi Sakagami; Qing Chu; James P Stables; Jonathan R Dimmock
Journal:  Bioorg Med Chem       Date:  2010-02-04       Impact factor: 3.641

4.  Sequential cytotoxicity: a theory examined using a series of 3,5-bis(benzylidene)-1-diethylphosphono-4-oxopiperidines and related phosphonic acids.

Authors:  Swagatika Das; Umashankar Das; Hiroshi Sakagami; Ken Hashimoto; Masami Kawase; Dennis K J Gorecki; Jonathan R Dimmock
Journal:  Bioorg Med Chem Lett       Date:  2010-09-17       Impact factor: 2.823

Review 5.  1,5-diaryl-3-oxo-1,4-pentadienes: a case for antineoplastics with multiple targets.

Authors:  U Das; R K Sharma; J R Dimmock
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

6.  1-Formyl-r-2,c-6-bis-(4-methoxy-phen-yl)-t-3-methyl-piperidin-4-one.

Authors:  P Gayathri; P Sakthivel; S Ponnuswamy; A Thiruvalluvar; R J Butcher
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-23

7.  Synthesis, characterization and anticancer activity of certain 3-{4-(5-mercapto-1,3,4-oxadiazole-2-yl)phenylimino}indolin-2-one derivatives.

Authors:  Rajyalakshmi Gudipati; Rama Narsimha Reddy Anreddy; Sarangapani Manda
Journal:  Saudi Pharm J       Date:  2011-03-11       Impact factor: 4.330

8.  2-(3-Aryl-2-propenoyl)-3-methylquinoxaline-1,4-dioxides: a novel cluster of tumor-specific cytotoxins which reverse multidrug resistance.

Authors:  Umashankar Das; Hari N Pati; Atulya K Panda; Erik De Clercq; Jan Balzarini; Joseph Molnár; Zoltán Baráth; Imre Ocsovszki; Masami Kawase; Li Zhou; Hiroshi Sakagami; Jonathan R Dimmock
Journal:  Bioorg Med Chem       Date:  2009-04-17       Impact factor: 3.641

9.  Curcumin analog cytotoxicity against breast cancer cells: exploitation of a redox-dependent mechanism.

Authors:  Aiming Sun; Yang J Lu; Haipeng Hu; Mamoru Shoji; Dennis C Liotta; James P Snyder
Journal:  Bioorg Med Chem Lett       Date:  2009-10-08       Impact factor: 2.823

10.  NC2213: a novel methionine aminopeptidase 2 inhibitor in human colon cancer HT29 cells.

Authors:  Ponniah Selvakumar; Ashakumary Lakshmikuttyamma; Umashankar Das; Hari N Pati; Jonathan R Dimmock; Rajendra K Sharma
Journal:  Mol Cancer       Date:  2009-08-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.